Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system

Bobin Mi , Yuan Xiong , Samuel Knoedler , Michael Alfertshofer , Adriana C. Panayi , Haixing Wang , Sien Lin , Gang Li , Guohui Liu

Bone Research ›› 2024, Vol. 12 ›› Issue (1) : 42

PDF
Bone Research ›› 2024, Vol. 12 ›› Issue (1) : 42 DOI: 10.1038/s41413-024-00346-4
Review Article

Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system

Author information +
History +
PDF

Abstract

Ageing as a natural irreversible process inherently results in the functional deterioration of numerous organ systems and tissues, including the skeletal and immune systems. Recent studies have elucidated the intricate bidirectional interactions between these two systems. In this review, we provide a comprehensive synthesis of molecular mechanisms of cell ageing. We further discuss how age-related skeletal changes influence the immune system and the consequent impact of immune system alterations on the skeletal system. Finally, we highlight the clinical implications of these findings and propose potential strategies to promote healthy ageing and reduce pathologic deterioration of both the skeletal and immune systems.

Cite this article

Download citation ▾
Bobin Mi, Yuan Xiong, Samuel Knoedler, Michael Alfertshofer, Adriana C. Panayi, Haixing Wang, Sien Lin, Gang Li, Guohui Liu. Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system. Bone Research, 2024, 12(1): 42 DOI:10.1038/s41413-024-00346-4

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Hou Y et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol., 2019, 15: 565-581

[2]

Tsukasaki M, Takayanagi H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol., 2019, 19: 626-642

[3]

Barbe-Tuana F et al. The interplay between immunosenescence and age-related diseases. Semin. Immunopathol., 2020, 42: 545-557

[4]

Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J. Hematol. Oncol., 2020, 13: 151

[5]

Chandra A, Rajawat J. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int. J. Mol. Sci., 2021, 22: 3553

[6]

Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin. Cell Dev. Biol., 2022, 123: 14-21

[7]

Fitzpatrick EA, Han X, Xiao Z, Quarles LD. Role of fibroblast growth factor-23 in innate immune responses. Front. Endocrinol. (Lausanne), 2018, 9: 320

[8]

Martin-Marquez BT et al. Osteopontin: a bone-derived protein involved in rheumatoid arthritis and osteoarthritis immunopathology. Biomolecules, 2023, 13: 502

[9]

Clezardin P et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol. Rev., 2021, 101: 797-855

[10]

Zioupos P, Kirchner HOK, Peterlik H. Ageing bone fractures: the case of a ductile to brittle transition that shifts with age. Bone, 2020, 131: 115176

[11]

Yokota K et al. Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis. Arthritis Rheumatol., 2021, 73: 1145-1154

[12]

Takeuchi T, Yoshida H, Tanaka S. Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis. Autoimmun. Rev., 2021, 20: 102884

[13]

Johannesdottir F et al. Age-related changes in bone density, microarchitecture, and strength in postmenopausal black and white women: the SWAN longitudinal HR-pQCT study. J. Bone Min. Res., 2022, 37: 41-51

[14]

Burr DB. Changes in bone matrix properties with aging. Bone, 2019, 120: 85-93

[15]

Alvarenga JC, Caparbo VF, Domiciano DS, Pereira RMR. Age-related reference data of bone microarchitecture, volumetric bone density, and bone strength parameters in a population of healthy Brazilian men: an HR-pQCT study. Osteoporos. Int, 2022, 33: 1309-1321

[16]

Pignolo RJ et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell, 2008, 7: 23-31

[17]

Guo Y et al. Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosis. Redox Biol., 2021, 41: 101915

[18]

Liu F et al. LRRc17 controls BMSC senescence via mitophagy and inhibits the therapeutic effect of BMSCs on ovariectomy-induced bone loss. Redox Biol., 2021, 43

[19]

Li H et al. FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging. J. Clin. Invest., 2017, 127: 1241-1253

[20]

Weng Z et al. Mesenchymal stem/stromal cell senescence: hallmarks, mechanisms, and combating Strategies. Stem Cells Transl. Med., 2022, 11: 356-371

[21]

Luo H et al. Cadmium exposure induces osteoporosis through cellular senescence, associated with activation of NF-kappaB pathway and mitochondrial dysfunction. Environ. Pollut., 2021, 290

[22]

Xiao Y et al. Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. EMBO J., 2023, 42: e111762

[23]

Hu M et al. NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation. Aging Cell, 2022, 21

[24]

Yang R et al. 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis. Aging Cell, 2020, 19

[25]

Lei Q et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Sci. Transl. Med., 2021, 13: eaaz8697

[26]

Chen S et al. lncRNA Xist regulates osteoblast differentiation by sponging miR-19a-3p in aging-induced osteoporosis. Aging Dis., 2020, 11: 1058-1068

[27]

Sherk VD, Rosen CJ. Senescent and apoptotic osteocytes and aging: exercise to the rescue? Bone, 2019, 121: 255-258

[28]

Ding P et al. Osteocytes regulate senescence of bone and bone marrow. Elife, 2022, 11: e81480

[29]

Cui J et al. Osteocytes in bone aging: Advances, challenges, and future perspectives. Ageing Res. Rev., 2022, 77

[30]

Eckhardt BA et al. Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes. JCI Insight, 2020, 5: e135236

[31]

Zhang Y et al. Neuronal Induction of Bone-Fat Imbalance through Osteocyte Neuropeptide Y. Adv. Sci. (Weinh.), 2021, 8

[32]

Kassem M, Marie PJ. Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell, 2011, 10: 191-197

[33]

Kim HN et al. DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. Aging Cell, 2017, 16: 693-703

[34]

Xu P et al. VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2/GPX4 pathway in age-related osteoporosis. Free Radic. Biol. Med., 2022, 193: 720-735

[35]

Kim HJ et al. ROS-induced PADI2 downregulation accelerates cellular senescence via the stimulation of SASP production and NFkappaB activation. Cell Mol. Life Sci., 2022, 79: 155

[36]

Chen A et al. mTORC1 induces plasma membrane depolarization and promotes preosteoblast senescence by regulating the sodium channel Scn1a. Bone Res., 2022, 10: 25

[37]

Lian WS et al. MicroRNA-29a mitigates osteoblast senescence and counteracts bone loss through oxidation resistance-1 control of FoxO3 Methylation. Antioxid. (Basel), 2021, 10: 1248

[38]

Kaur J et al. MicroRNA-19a-3p decreases with age in mice and humans and inhibits osteoblast senescence. JBMR, 2023, 7

[39]

Kim HN et al. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight, 2020, 5: e138815

[40]

Geng Q et al. Pyrroloquinoline quinone prevents estrogen deficiency-induced osteoporosis by inhibiting oxidative stress and osteocyte senescence. Int. J. Biol. Sci., 2019, 15: 58-68

[41]

Wang X et al. Enhancement of bone-forming ability on beta-tricalcium phosphate by modulating cellular senescence mechanisms using senolytics. Int J. Mol. Sci., 2021, 22: 12415

[42]

Gorissen B et al. Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis. J. Cell Physiol., 2018, 234: 414-426

[43]

Chen W et al. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. Hum. Mol. Genet., 2007, 16: 410-423

[44]

Pimenta-Lopes C et al. Inhibition of C5AR1 impairs osteoclast mobilization and prevents bone loss. Mol. Ther., 2023, 31: 2507-2523

[45]

Kim HN et al. Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice. Aging Cell, 2019, 18

[46]

Samakkarnthai P et al. In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers. Aging (Albany NY), 2023, 15: 3331-3355

[47]

Li Z et al. Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits. Elife, 2022, 11: e78496

[48]

Liu X et al. Oxylipin-PPARgamma-initiated adipocyte senescence propagates secondary senescence in the bone marrow. Cell Metab., 2023, 35: 667-684.e666

[49]

Ungvari Z et al. Mechanisms of vascular aging, a geroscience perspective: JACC focus seminar. J. Am. Coll. Cardiol., 2020, 75: 931-941

[50]

Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature, 2014, 507: 323-328

[51]

Tuckermann J, Adams RH. The endothelium-bone axis in development, homeostasis and bone and joint disease. Nat. Rev. Rheumatol., 2021, 17: 608-620

[52]

Kusumbe AP et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature, 2016, 532: 380-384

[53]

Xiao X et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src. Signal Transduct. Target Ther., 2021, 6: 354

[54]

Saul D et al. Modulation of fracture healing by the transient accumulation of senescent cells. Elife, 2021, 10: e69958

[55]

Zeng X et al. Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation. Blood, 2023, 141: 1691-1707

[56]

Kasbekar M, Mitchell CA, Proven MA, Passegue E. Hematopoietic stem cells through the ages: A lifetime of adaptation to organismal demands. Cell Stem Cell, 2023, 30: 1403-1420

[57]

Wang M et al. Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner. Mol. Cell, 2023, 83: 2417-2433.e2417

[58]

Bogeska R et al. Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell, 2022, 29: 1273-1284.e1278

[59]

Shevyrev D, Tereshchenko V, Berezina TN, Rybtsov S. Hematopoietic stem cells and the immune system in development and aging. Int. J. Mol. Sci., 2023, 24: 5862

[60]

Ambrosi TH et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature, 2021, 597: 256-262

[61]

Ramalingam P et al. Restoring bone marrow niche function rejuvenates aged hematopoietic stem cells by reactivating the DNA Damage Response. Nat. Commun., 2023, 14

[62]

Nakamura-Ishizu A, Ito K, Suda T. Hematopoietic stem cell metabolism during development and aging. Dev. Cell, 2020, 54: 239-255

[63]

Ji ML et al. Sirt6 attenuates chondrocyte senescence and osteoarthritis progression. Nat. Commun., 2022, 13

[64]

Zhang H et al. Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7. Ann. Rheum. Dis., 2022, 81: 676-686

[65]

Cao H et al. MYL3 protects chondrocytes from senescence by inhibiting clathrin-mediated endocytosis and activating of Notch signaling. Nat. Commun., 2023, 14

[66]

Shen P et al. LncRNA AC006064.4-201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1. Biomark. Res, 2023, 11

[67]

Gong Z et al. CircZSWIM6 mediates dysregulation of ECM and energy homeostasis in ageing chondrocytes through RPS14 post-translational modification. Clin. Transl. Med., 2023, 13

[68]

Chen X et al. METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann. Rheum. Dis., 2022, 81: 87-99

[69]

Liu F et al. Identification of FOXO1 as a geroprotector in human synovium through single-nucleus transcriptomic profiling. Protein Cell, 2023, 15: 441-459

[70]

Zhou J et al. Identification of aging-related biomarkers and immune infiltration characteristics in osteoarthritis based on bioinformatics analysis and machine learning. Front. Immunol., 2023, 14

[71]

Pessler F et al. A histomorphometric analysis of synovial biopsies from individuals with Gulf War Veterans’ Illness and joint pain compared to normal and osteoarthritis synovium. Clin. Rheumatol., 2008, 27: 1127-1134

[72]

Li YS, Luo W, Zhu SA, Lei GHT. Cells in osteoarthritis: alterations and beyond. Front. Immunol., 2017, 8: 356

[73]

Ko CY et al. Omentin-1 ameliorates the progress of osteoarthritis by promoting IL-4-dependent anti-inflammatory responses and M2 macrophage polarization. Int J. Biol. Sci., 2023, 19: 5275-5289

[74]

Grieshaber-Bouyer R et al. Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. Ann. Rheum. Dis., 2022, 81: 805-814

[75]

Barbouti A et al. Implications of oxidative stress and cellular senescence in age-related thymus involution. Oxid. Med. Cell Longev., 2020, 2020

[76]

Spits H. Development of alphabeta T cells in the human thymus. Nat. Rev. Immunol., 2002, 2: 760-772

[77]

Pinho S, Frenette PS. Haematopoietic stem cell activity and interactions with the niche. Nat. Rev. Mol. Cell Biol., 2019, 20: 303-320

[78]

Mei Y et al. Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia. J. Clin. Invest., 2022, 132: e152673

[79]

Soto-Heredero G, Gomez de Las Heras MM, Escrig-Larena JI, Mittelbrunn M. Extremely differentiated T cell subsets contribute to tissue deterioration during aging. Annu. Rev. Immunol., 2023, 41: 181-205

[80]

Zhang H et al. Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses. Nat. Immunol., 2023, 24: 96-109

[81]

Bignon A et al. DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia. Blood, 2015, 125: 2507-2518

[82]

Hasegawa T et al. Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen. Cell, 2023, 186: 1417-1431.e1420

[83]

Lorenzo EC et al. Senescence-induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics. Aging Cell, 2022, 21

[84]

Nian Y et al. Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival. Aging Cell, 2021, 20

[85]

Xiong Y et al. hPMSCs-derived exosomal miRNA-21 protects against aging-related oxidative damage of CD4+ T cells by targeting the PTEN/PI3K-Nrf2 axis. Front. Immunol., 2021, 12

[86]

Song Y et al. T-cell immunoglobulin and ITIM domain contributes to CD8+ T-cell immunosenescence. Aging Cell, 2018, 17: e12716

[87]

Callender LA et al. Human CD8+ EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK. Aging Cell, 2018, 17: e12675

[88]

Marin I et al. Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discov., 2023, 13: 410-431

[89]

Delpoux A et al. FOXO1 constrains activation and regulates senescence in CD8 T cells. Cell Rep., 2021, 34

[90]

Gustafson CE et al. Functional pathways regulated by microRNA networks in CD8 T-cell aging. Aging Cell, 2019, 18

[91]

Ye J et al. Human regulatory T cells induce T-lymphocyte senescence. Blood, 2012, 120: 2021-2031

[92]

Guo Z et al. DCAF1 regulates Treg senescence via the ROS axis during immunological aging. J. Clin. Invest., 2020, 130: 5893-5908

[93]

Li L et al. TLR8-mediated metabolic control of human Treg function: a mechanistic target for cancer immunotherapy. Cell Metab., 2019, 29: 103-123.e105

[94]

Danileviciute E et al. PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains T(reg) homeostasis during ageing. Nat. Metab., 2022, 4: 589-607

[95]

Cancro MP. Age-associated B cells. Annu. Rev. Immunol., 2020, 38: 315-340

[96]

Riley RL et al. Deficient B lymphopoiesis in murine senescence: potential roles for dysregulation of E2A, Pax-5, and STAT5. Semin. Immunol., 2005, 17: 330-336

[97]

Cepeda S et al. Age-associated decline in thymic B cell expression of aire and aire-dependent self-antigens. Cell Rep., 2018, 22: 1276-1287

[98]

Zhang H et al. Polyamines control eIF5A hypusination, TFEB translation, and autophagy to reverse B cell senescence. Mol. Cell, 2019, 76: 110-125.e119

[99]

de Mol J, Kuiper J, Tsiantoulas D, Foks AC. The dynamics of B cell aging in health and disease. Front. Immunol., 2021, 12: 733566

[100]

Landin AM et al. E47 retroviral rescue of intrinsic B-cell defects in senescent mice. Aging Cell, 2011, 10: 327-337

[101]

Rawji KS et al. Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. Brain, 2016, 139: 653-661

[102]

Wang Q et al. Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging. Int. J. Oral. Sci., 2021, 13: 11

[103]

Schloesser D et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis. J. Cell Biol., 2023, 222: e202207097

[104]

Wang H et al. BRD4 contributes to LPS-induced macrophage senescence and promotes progression of atherosclerosis-associated lipid uptake. Aging (Albany NY), 2020, 12: 9240-9259

[105]

Barkaway A et al. Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage. Immunity, 2021, 54: 1494-1510.e1497

[106]

Minton K. Neutrophils hit reverse in ageing. Nat. Rev. Immunol., 2021, 21: 408-409

[107]

Ward JR et al. Regulation of neutrophil senescence by microRNAs. PLoS One, 2011, 6: e15810

[108]

Guo C et al. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19. Genome Med., 2022, 14

[109]

Bai Z et al. Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice. Cell Death Dis., 2022, 13

[110]

Chakraborty M et al. Mechanical stiffness controls dendritic cell metabolism and function. Cell Rep., 2021, 34

[111]

Wong C, Goldstein DR. Impact of aging on antigen presentation cell function of dendritic cells. Curr. Opin. Immunol., 2013, 25: 535-541

[112]

Young K et al. Decline in IGF1 in the bone marrow microenvironment initiates hematopoietic stem cell aging. Cell Stem Cell, 2021, 28: 1473-1482.e1477

[113]

Valletta S et al. Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFbeta1 as regulators of hematopoietic ageing. Nat. Commun., 2020, 11

[114]

Ratliff M et al. In aged mice, low surrogate light chain promotes pro-B-cell apoptotic resistance, compromises the PreBCR checkpoint, and favors generation of autoreactive, phosphorylcholine-specific B cells. Aging Cell, 2015, 14: 382-390

[115]

Colom Diaz PA, Mistry JJ, Trowbridge JJ. Hematopoietic stem cell aging and leukemia transformation. Blood, 2023, 142: 533-542

[116]

Li X et al. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct. Target Ther., 2023, 8: 239

[117]

Kuribayashi W et al. Limited rejuvenation of aged hematopoietic stem cells in young bone marrow niche. J. Exp. Med., 2021, 218: e20192283

[118]

Zhang X et al. Harnessing matrix stiffness to engineer a bone marrow niche for hematopoietic stem cell rejuvenation. Cell Stem Cell, 2023, 30: 378-395.e378

[119]

Maryanovich M et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat. Med., 2018, 24: 782-791

[120]

Yu Z et al. Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches. Blood, 2022, 139: 1529-1540

[121]

Chen J et al. Interleukin 6-regulated macrophage polarization controls atherosclerosis-associated vascular intimal hyperplasia. Front. Immunol., 2022, 13

[122]

Yan Y et al. Interleukin-6 produced by enteric neurons regulates the number and phenotype of microbe-responsive regulatory T cells in the gut. Immunity, 2021, 54: 499-513.e495

[123]

Pritz T, Weinberger B, Grubeck-Loebenstein B. The aging bone marrow and its impact on immune responses in old age. Immunol. Lett., 2014, 162: 310-315

[124]

Liu S et al. Endothelial IL-8 induced by porcine circovirus type 2 affects dendritic cell maturation and antigen-presenting function. Virol. J., 2019, 16: 154

[125]

Labrie JE 3rd, Borghesi L, Gerstein RM. Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generation. Semin. Immunol., 2005, 17: 347-355

[126]

Jin G et al. MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development. EMBO J., 2011, 30: 2281-2293

[127]

Petillo S et al. NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells. Cell Death Dis., 2023, 14

[128]

Xiong, Y. et al. Metal-organic frameworks and their composites for chronic wound healing: From bench to bedside. Adv. Mater. e2302587 (2023)

[129]

Benet Z, Jing Z, Fooksman DR. Plasma cell dynamics in the bone marrow niche. Cell Rep., 2021, 34: 108733

[130]

Fessler J et al. Senescent T-cells promote bone loss in rheumatoid arthritis. Front. Immunol., 2018, 9: 95

[131]

Faust HJ et al. IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis. J. Clin. Invest., 2020, 130: 5493-5507

[132]

Li JY et al. The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. J. Bone Min. Res., 2014, 29: 43-54

[133]

O’Neil LJ et al. Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis. Ann. Rheum. Dis., 2023, 82: 630-638

[134]

Hale SJ et al. CXCR2 modulates bone marrow vascular repair and haematopoietic recovery post-transplant. Br. J. Haematol., 2015, 169: 552-564

[135]

Li J et al. TGFbeta1+ CCR5+ neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice. Nat. Commun., 2023, 14

[136]

Clark D et al. Age-related changes to macrophages are detrimental to fracture healing in mice. Aging Cell, 2020, 19

[137]

Gibon E et al. Aging affects bone marrow macrophage polarization: relevance to bone healing. Regen. Eng. Transl. Med., 2016, 2: 98-104

[138]

Li CJ et al. Senescent immune cells release grancalcin to promote skeletal aging. Cell Metab., 2021, 33: 1957-1973.e1956

[139]

Titanji K et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS Pathog., 2014, 10: e1004497

[140]

Titanji K. Beyond antibodies: B cells and the OPG/RANK-RANKL pathway in health, non-HIV disease and HIV-induced bone loss. Front. Immunol., 2017, 8: 1851

[141]

Li Y et al. B cell production of both OPG and RANKL is significantly increased in aged mice. Open Bone J., 2014, 6: 8-17

[142]

Grolleau-Julius A et al. Effect of aging on bone marrow-derived murine CD11c+CD4CD8alpha dendritic cell function. J. Gerontol. A Biol. Sci. Med. Sci., 2006, 61: 1039-1047

[143]

Farr JN et al. Identification of senescent cells in the bone microenvironment. J. Bone Min. Res., 2016, 31: 1920-1929

[144]

Shin MS, Park HJ, Young J, Kang I. Implication of IL-7 receptor alpha chain expression by CD8+ T cells and its signature in defining biomarkers in aging. Immun. Ageing, 2022, 19: 66

[145]

Dhanabalan KM et al. Intra-articular injection of rapamycin microparticles prevent senescence and effectively treat osteoarthritis. Bioeng. Transl. Med., 2023, 8

[146]

Liu W et al. Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells. Bone Res., 2018, 6: 27

[147]

Wang Y et al. Repurpose dasatinib and quercetin: targeting senescent cells ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration. Bioact. Mater., 2023, 25: 13-28

[148]

Peng H et al. A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis. Cell Metab., 2022, 34: 1168-1182.e1166

[149]

Yang X et al. T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg/Th17 balance. Bioact. Mater., 2021, 6: 3150-3163

[150]

Chen Y et al. Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis. Theranostics, 2022, 12: 1074-1096

[151]

Farr JN et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med, 2017, 23: 1072-1079

[152]

Cheng A et al. Early systemic immune biomarkers predict bone regeneration after trauma. Proc. Natl. Acad. Sci. USA, 2021, 118: e2017889118

[153]

Shields AF. Imaging bone-marrow activity with (18)F-fluorothymidine PET. Lancet Haematol., 2018, 5: e8-e9

[154]

Yousefzadeh MJ et al. An aged immune system drives senescence and ageing of solid organs. Nature, 2021, 594: 100-105

[155]

Yan S et al. Metformin regulates chondrocyte senescence and proliferation through microRNA-34a/SIRT1 pathway in osteoarthritis. J. Orthop. Surg. Res., 2023, 18: 198

[156]

Landry DA et al. Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice. Sci. Adv., 2022, 8

[157]

Yang J et al. The effect of metformin on senescence of T lymphocytes. Immun. Ageing, 2023, 20: 73

[158]

Liu J et al. Age-associated callus senescent cells produce TGF-beta1 that inhibits fracture healing in aged mice. J. Clin. Invest., 2022, 132: e148073

[159]

Dai H et al. Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA. Stem Cell Res. Ther., 2020, 11: 199

[160]

Iske J et al. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nat. Commun., 2020, 11

[161]

Griveau A et al. The JAK1/2 inhibitor ruxolitinib delays premature aging phenotypes. Aging Cell, 2020, 19

[162]

Ledesma-Colunga MG et al. Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis. Redox Biol., 2023, 60

[163]

Xu M et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl. Acad. Sci. USA, 2015, 112: E6301-E6310

[164]

Hambright WS et al. The senolytic drug fisetin attenuates bone degeneration in the Zmpste24 /− progeria mouse model. J. Osteoporos., 2023, 2023

[165]

Jia Q et al. Fisetin, via CKIP-1/REGgamma, limits oxidized LDL-induced lipid accumulation and senescence in RAW264.7 macrophage-derived foam cells. Eur. J. Pharm., 2019, 865

[166]

Chang J et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med., 2016, 22: 78-83

[167]

Miura Y, Endo K, Komori K, Sekiya I. Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients. Stem Cell Res. Ther., 2022, 13: 222

[168]

Yang H et al. Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis. Aging (Albany NY), 2020, 12: 12750-12770

[169]

Chung L et al. Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans. Sci. Transl. Med., 2020, 12: eaax3799

[170]

Hernandez-Silva D et al. Senescence-independent anti-inflammatory activity of the senolytic drugs dasatinib, navitoclax, and venetoclax in zebrafish models of chronic inflammation. Int. J. Mol. Sci., 2022, 23: 10468

[171]

Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B vitamins and their role in immune regulation and cancer. Nutrients, 2020, 12: 3380

[172]

Clements M et al. A 2-year randomized controlled trial with low-dose B-vitamin supplementation shows benefits on bone mineral density in adults with lower B12 status. J. Bone Min. Res, 2022, 37: 2443-2455

[173]

Hong H et al. Associations of homocysteine, folate, and vitamin B12 with osteoarthritis: a mendelian randomization study. Nutrients, 2023, 15: 1636

[174]

Carr AC, Maggini S. Vitamin C and immune function. Nutrients, 2017, 9: 1211

[175]

Thaler R et al. Vitamin C epigenetically controls osteogenesis and bone mineralization. Nat. Commun., 2022, 13

[176]

Blouin S et al. Vitamin C deficiency deteriorates bone microarchitecture and mineralization in a sex-specific manner in adult mice. J. Bone Min. Res., 2023, 38: 1509-1520

[177]

Fantini C et al. Vitamin D as a shield against aging. Int. J. Mol. Sci., 2023, 24: 4546

[178]

van Driel M, van Leeuwen J. Vitamin D and bone: a story of endocrine and auto/paracrine action in osteoblasts. Nutrients, 2023, 15: 480

[179]

Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life, 2019, 71: 487-494

[180]

Nazrun Shuid A, Das S, Mohamed IN. Therapeutic effect of Vitamin E in preventing bone loss: an evidence-based review. Int. J. Vitam. Nutr. Res., 2019, 89: 357-370

[181]

Cui A et al. Associations between vitamin E status and bone mineral density in children and adolescents aged 8-19 years: evidence based on NHANES 2005-2006, 2017-2018. PLoS One, 2023, 18: e0283127

[182]

Hatanaka H et al. Effects of vitamin K3 and K5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells. Life Sci., 2014, 99: 61-68

[183]

Mandatori D et al. The dual role of vitamin K2 in “Bone-Vascular Crosstalk”: opposite effects on bone loss and vascular calcification. Nutrients, 2021, 13: 1222

[184]

Tsugawa N, Shiraki M. Vitamin K nutrition and bone health. Nutrients, 2020, 12: 1909

[185]

Yang L et al. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. J. Hematol. Oncol., 2023, 16: 59

[186]

Lv Z, Shi W, Zhang Q. Role of essential amino acids in age-induced bone loss. Int. J. Mol. Sci., 2022, 23: 11281

[187]

Bachem A et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T Cells. Immunity, 2019, 51: 285-297.e285

[188]

Tan JK, Macia L, Mackay CR. Dietary fiber and SCFAs in the regulation of mucosal immunity. J. Allergy Clin. Immunol., 2023, 151: 361-370

[189]

Yang KL et al. Short chain fatty acids mitigate osteoclast-mediated arthritic bone remodelling. Arthritis Rheumatol., 2023, 76: 647-659

[190]

Lucas S et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat. Commun., 2018, 9

[191]

Hidalgo MA, Carretta MD, Burgos RA. Long chain fatty acids as modulators of immune cells function: Contribution of FFA1 and FFA4 receptors. Front. Physiol., 2021, 12: 668330

[192]

Abshirini M, Ilesanmi-Oyelere BL, Kruger MC. Potential modulatory mechanisms of action by long-chain polyunsaturated fatty acids on bone cell and chondrocyte metabolism. Prog. Lipid Res., 2021, 83: 101113

Funding

Research Grants Council, University Grants Committee (RGC, UGC)(N_CUHK472/22, T13-402/17-N and AoE/M-402/20)

Chinese University of Hong Kong (CUHK)(2022.042)

Wuhan Municipal Science and Technology Bureau (Wuhan Intellectual Property Bureau)(2022020801020464)

AI Summary AI Mindmap
PDF

169

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/